Patents by Inventor Jean-Marie Schneider

Jean-Marie Schneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR THE PREPARATION OF (3S,3S') 4,4'-DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID)
    Publication number: 20160046571
    Abstract: The present invention relates to a new method for the preparation of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) in five steps from (S)-ethyl 2-(benzyloxycarbonylamino)-4-(neopentyloxysulfonyl)butanoate A.
    Type: Application
    Filed: October 27, 2015
    Publication date: February 18, 2016
    Inventors: Fabrice BALAVOINE, Jonathan MADEC, Jean-Marie SCHNEIDER, Gerard COQUEREL, Nicolas COUVRAT, Yohann CARTIGNY, Marie-Noelle PETIT
  • Method for the preparation of (3S, 3S?) 4,4?-disulfanediylbis (3-aminobutane 1-sulfonic acid)
    Patent number: 9187418
    Abstract: The present invention relates to a new method for the preparation of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) in five steps from (S)-ethyl 2-(benzyloxycarbonylamino)-4-(neopentyloxysulfonyl)butanoate A.
    Type: Grant
    Filed: October 7, 2011
    Date of Patent: November 17, 2015
    Assignee: QUANTUM GENOMICS
    Inventors: Fabrice Balavoine, Jonathan Madec, Jean-Marie Schneider, Gérard Coquerel, Nicolas Couvrat, Yohann Cartigny, Marie-Noëlle Petit
  • CRYSTALLINE PHASE OF (3S.3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) WITH L-LYSINE
    Publication number: 20150284325
    Abstract: The present invention relates to a new crystalline phase of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) (ABSD) with L-lysine and its use, particularly in the pharmaceutical industry, and to processes for preparation thereof. The invention is also directed to pharmaceutical compositions containing at least one crystalline phase of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) (ABSD) with L-lysine and to the therapeutic or prophylactic use of such crystalline phase and compositions comprising the same.
    Type: Application
    Filed: October 22, 2013
    Publication date: October 8, 2015
    Applicant: Quantum Genomics
    Inventors: Fabrice Balavoine, Jean-Marie Schneider, Gérard Coquerel, Nicolas Couvrat
  • Process for Preparing Cinacalcet and Pharmaceutically Acceptable Salts Thereof
    Publication number: 20150246869
    Abstract: The present patent application relates to a process for preparing, cinacalcet or a pharmaceutically acceptable salt thereof, which comprises reacting 3-trifluoromethylbenzaldehyde having the following formula (II) with the phosphorus-comprising derivative having the following formula all) in which R1 and R2, which may he identical or different, are each a (C1-C6)alkyl group. The present invention also relates to the phosphorus-comprising derivative having the formula (III), to the use thereof and to the process for preparing same. The present invention also relates to the phosphate salt of cinacalcet and to uses thereof.
    Type: Application
    Filed: September 9, 2013
    Publication date: September 3, 2015
    Inventors: Jean-Marie Schneider, Jonathan Madec, Sergio Kreimerman, Gerard Guillamot
  • Process
    Publication number: 20140221668
    Abstract: The present invention relates to a process for preparing (R)-5-(2-(benzylamino)ethyl)-1-(6,8-difluorochroman-3-yl)-1H-imidazole-2(3H)-thione, and pharmaceutically acceptable salts thereof, especially the hydrochloride salt. The invention also relates to a process for making intermediates useful in the formation of said compound, and to the intermediates, per se.
    Type: Application
    Filed: June 29, 2012
    Publication date: August 7, 2014
    Applicant: BIAL-PORTELA & CA, S.A.
    Inventors: Alexander Beliaev, Jorge Bruno Reis Wahnon, David Alexander Learmonth, Jonathan Madec, Jean-Marie Schneider, William Maton
  • Precursor phase and use thereof for preparing the magnesium tetrahydrate salt of an omeprazole enantiomer
    Patent number: 8592601
    Abstract: A precursor phase of the magnesium tetrahydrate salt of an omeprazole enantiomer, and also processes for preparing it and its use for the preparation of the magnesium tetrahydrate salt are described. Crystals of the magnesium tetrahydrate salt thus obtained, and their uses, especially in the synthesis of the dihydrate form A of the magnesium salt of the enantiomer or as medicament are also disclosed.
    Type: Grant
    Filed: March 31, 2011
    Date of Patent: November 26, 2013
    Assignees: Produits Chimiques Auxiliaires et de Synthese, Universite de Rouen
    Inventors: Snella Chouippe, Jean-Marie Schneider, Guillaume Tauvel, Gerard Coquerel
  • METHOD FOR THE PREPARATION OF (3S, 3S') 4,4'-DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID)
    Publication number: 20130231500
    Abstract: The present invention relates to a new method for the preparation of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) in five steps from (S)-ethyl 2-(benzyloxycarbonylamino)-4-(neopentyloxysulfonyl)butanoate A.
    Type: Application
    Filed: October 7, 2011
    Publication date: September 5, 2013
    Applicant: QUANTUM GEOMICS
    Inventors: Fabrice Balavoine, Jonathan Madec, Jean-Marie Schneider, Gérard Coquerel, Nicolas Couvrat, Yohann Cartigny, Marie-Noëlle Petit
  • PRECURSOR PHASE AND USE THEREOF FOR PREPARING THE MAGNESIUM TETRAHYDRATE SALT OF AN OMEPRAZOLE ENANTIOMER
    Publication number: 20110269798
    Abstract: A precursor phase of the magnesium tetrahydrate salt of an omeprazole enantiomer, and also processes for preparing it and its use for the preparation of the magnesium tetrahydrate salt are described. Crystals of the magnesium tetrahydrate salt thus obtained, and their uses, especially in the synthesis of the dihydrate form A of the magnesium salt of the enantiomer or as medicament are also disclosed.
    Type: Application
    Filed: March 31, 2011
    Publication date: November 3, 2011
    Applicants: UNIVERSITE DE ROUEN, PRODUITS CHIMIQUES AUXILIAIRES ET DE SYNTHESE
    Inventors: Snella CHOUIPPE, Jean-Marie SCHNEIDER, Guillaume TAUVEL, Gerard COQUEREL
  • Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation
    Patent number: 7619116
    Abstract: A subject matter of the present invention is novel intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts, and also the associated preparation process.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: November 17, 2009
    Assignee: Products Chimiques Auxiliaires Et de Synthese
    Inventors: Valéry Dambrin, Jean-Yves Lenoir, Jean-Marie Schneider, Gérard Guillamot, Michel Follet, Abram Becker
  • Novel intermediates for the synthesis of (r)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation
    Publication number: 20070106079
    Abstract: A subject matter of the present invention is novel intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts, and also the associated preparation process.
    Type: Application
    Filed: December 15, 2004
    Publication date: May 10, 2007
    Inventors: Valéry Dambrin, Jean-Yves Lenoir, Jean-Marie Schneider, Gerard Guillamot, Michel Follet, Abram Becker